Bernard Vandercam

Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR

Pascal Vannuffel, J. Gigi, H Ezzedine et al. · Journal of Clinical Microbiology · 1995 · 312 citations · Full text

Amplification Steps, Disease Resistance, Antimicrobial Resistance Gene +15

An EORTC International Multicenter Randomized Trial (EORTC Number 19923) Comparing Two Dosages of Liposomal Amphotericin B for Treatment of Invasive Aspergillosis

Michael Ellis, David J. Spence, Ben de Pauw et al. · Clinical Infectious Diseases · 1998 · 253 citations · Full text

Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial

Chloe Orkin, Jean‐Michel Molina, Eugènia Negredo et al. · The Lancet HIV · 2017 · 96 citations

Protease Inhibitors, Treatment And Prevention, Pharmacology +9

Epidemiology and prevention ofClostridium difficile infections in a leukemia unit

Michel Delmée, Bernard Vandercam, V. Avesani et al. · European Journal of Clinical Microbiology & Infectious Diseases · 1987 · 79 citations

Preventive Medicine, Antimicrobial Susceptibility, Antibiotics +10

Low molecular weight proteinuria in human immunodeficiency virus-infected patients

André Kabanda, Bernard Vandercam, Alfred Bernard et al. · American Journal of Kidney Diseases · 1996 · 65 citations

Primary Immunodeficiency, Glomerulonephritis, Urology +7